Genocea Biosciences, Inc.
Cambridge, Massachusetts, United States
Purpose
to identify novel protein antigens that could, either by themselves or in combination with existing antigens, afford superior protective efficacy against malaria and pave the road towards an affordable, mass-produced prophylactic vaccine
Division
Global Health
Date
August 2014
Region Served
GLOBAL
Committed amount
$1,183,592
Grant topic
Malaria
Duration (months)
25
Grantee location
Cambridge, Massachusetts, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.